Article

Diagnostic Inflation Causes and a Suggested Cure

Department of Special Needs Education and Child Care, University of Groningen, Groningen, the Netherlands.
The Journal of nervous and mental disease (Impact Factor: 1.69). 06/2012; 200(6):474-9. DOI: 10.1097/NMD.0b013e318257c4a2
Source: PubMed

ABSTRACT

There have been a striking diagnostic inflation and a corresponding increase in the use of psychotropic drugs during the past 30 years. DSM-5, scheduled to appear in May 2013, proposes another grand expansion of mental illness. In this article, we will review the causes of diagnostic exuberance and associated medical treatment. We will then suggest a method of stepped care combined with stepped diagnosis, which may reduce overdiagnosis without risking undertreatment of those who really need help. The goal is to control diagnostic inflation, to reduce the harms and costs of unnecessary treatment, and to save psychiatry from overdiagnosis and ridicule.

Download full-text

Full-text

Available from: Laura Batstra, Sep 30, 2014
  • Source
    • "Because of this expanded category of depression, on the macro scale in terms of public health, there could be a growth in the number of individuals who will be considered clinically depressed as well as increased and possibly unnecessary spending on health care for the treatment of those considered to have a mental illness. Over the past 30 years there has been a ''diagnostic inflation'' in which active efforts by pharmaceutical companies to market drugs have increased the number of individuals considered to have a psychiatric disorder (Batstra & Frances, 2012); the number of individuals treated with psychotropic drugs will only increase with the DSM-5. On a more microlevel scale, the question of how the diagnosis of major depression following the loss of a loved one will influence the bereaved individual's ability to recover and overcome his or her grief is an important consideration. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This article examines the recently published changes to eliminate the bereavement exclusion (BE) from the criteria for the diagnosis of major depression in the fifth edition of the Diagnostic and Statistical Manual (DSM-5). Numerous scholars and critics have expressed concerns by calling these changes a "medicalization" of grief. This article first considers the removal of the BE and then examines the macrolevel and microlevel consequences of this medicalization of grief, including overdiagnosis and overtreatment, a potential expanded market for pharmaceutical companies, and the loss of traditional and cultural methods of adapting to the loss of a loved one.
    Preview · Article · Apr 2015 · Death Studies
  • [Show abstract] [Hide abstract]
    ABSTRACT: The American Psychiatric Association (APA) published DSM-5 in May 2013. The revision process was fraught with controversy. In the first section of this article, we briefly summarise the controversies related to the actions of the APA and the Task Force responsible for the revision process. These include allegations of secrecy, accusations of conflicts of interest, apprehension over a promised paradigm shift, concerns about the definition of mental disorder, charges of medicalizing normality, and claims of poor methodology. In the second section, we briefly summarise the controversies related to some of the revisions to the DSM-5 disorders and diagnostic criteria. In the third section, we argue that DSM-5 development was unnecessarily contentious for reasons that could have been foreseen and prevented. Because incremental updates to the DSM-5 are anticipated in the near future (American Psychiatric Association, 2010, APA modifies DSM naming convention to reflect publication changes, Washington, DC: Author), we propose that psychologists external to the revision process should use their unique expertise to assist in resolving the controversies that have beset the DSM-5 and thereby facilitate a less contentious development of the next iteration of the DSM. (PsycINFO Database Record (c) 2013 APA, all rights reserved)
    No preview · Article · Jan 2013 · Canadian Psychology

  • No preview · Article · Jan 2013 · Australian and New Zealand Journal of Psychiatry
Show more